Equillium, Inc. (EQ) Key Metrics
EQ valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $75.5M
- Enterprise value
- $54.4M
- P/E (TTM)
- —
- Forward P/E
- 1.5
- PEG ratio
- —
- Price / sales
- 20.2 10-yr median 0.7
- Price / book
- 2.2 10-yr median 1.4
- EV / EBITDA
- 0.1
- Dividend yield
- —
- Beta
- 1.92
EQ key metrics, 2017–2025
Fiscal year ended December 31, 2025 · U.S. dollarsEQ valuation Price multiples at each fiscal year-end price.
EQ returns How much profit the business earns on the capital it uses.
EQ per-share figures Results divided by the shares outstanding at year-end.
EQ financial health Debt, liquidity and how easily interest is covered.
EQ efficiency & capital use Working capital cycle and where the cash goes.
EQ valuation history
EQ returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
EQ debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
EQ cash returned to shareholders
EQ price vs earnings per share
EQ key metrics
2017–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||
| Market capitalization | $142.4M | $26.5M | $25.1M | $35.8M | $108.6M | $108.9M | $58.7M | — | — |
| Enterprise value | $112.9M | $4.3M | −$14.9M | −$25.1M | $38.4M | $36.7M | $15.3M | — | — |
| Price / sales | — | 0.6 | 0.7 | 2.3 | — | — | — | — | — |
| Price / book | 5.0 | 1.4 | 1.1 | 1.1 | 1.6 | 1.6 | 1.4 | — | — |
| EV / sales | 868.1 | 0.1 | -0.4 | -1.6 | — | — | — | — | — |
| Earnings yield | −15.7% | −30.5% | −53.1% | −174.6% | −35.9% | −27.3% | −43.5% | — | — |
| Free cash flow yield | −16.0% | −72.2% | −87.0% | −25.2% | −29.6% | −22.8% | −39.2% | — | — |
| Dividend yield | — | — | 36.4% | — | — | — | 16.8% | — | — |
| Shareholder yield (dividends + buybacks) | — | 0.0% | 37.4% | 0.0% | 0.0% | 0.0% | 17.1% | — | — |
| Share price at fiscal year-end | $1.55 | $0.75 | $0.72 | $1.06 | $3.77 | $5.35 | $3.38 | $8.16 | — |
| Per share | |||||||||
| Revenue per share | $0.00 | $1.16 | $1.04 | $0.47 | $0.00 | $0.00 | $0.00 | — | $0.00 |
| Earnings per share | −$0.24 | −$0.23 | −$0.38 | −$1.85 | −$1.35 | −$1.46 | −$1.47 | — | −$0.14 |
| Operating cash flow per share | −$0.25 | −$0.54 | −$0.63 | −$0.26 | −$1.11 | −$1.21 | −$1.32 | — | −$0.04 |
| Free cash flow per share | −$0.25 | −$0.54 | −$0.63 | −$0.27 | −$1.12 | −$1.22 | −$1.32 | — | −$0.04 |
| Cash per share | $0.33 | $0.64 | $1.18 | $2.11 | $2.80 | $4.04 | $3.06 | — | $0.43 |
| Book value per share | $0.31 | $0.54 | $0.65 | $0.95 | $2.31 | $3.43 | $2.41 | — | −$0.13 |
| Tangible book value per share | $0.31 | $0.54 | $0.65 | $0.95 | $2.31 | $3.43 | $2.41 | — | −$0.13 |
| Dividends per share | — | — | $0.26 | — | — | — | $0.57 | — | — |
| Capex per share | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.01 | $0.00 | — | $0.00 |
| Debt per share | $0.01 | $0.01 | $0.02 | $0.30 | $0.37 | $0.49 | $0.56 | — | $0.97 |
| Shares outstanding | 91.9M | 35.4M | 34.7M | 33.7M | 28.8M | 20.4M | 17.4M | — | 16.7M |
| Change in shares outstanding | +159.9% | +1.8% | +3.0% | +17.1% | +41.5% | +17.1% | — | — | — |
| Returns & profitability | |||||||||
| Return on equity (ROE) | −94.0% | −38.8% | −48.9% | −126.8% | −57.2% | −53.3% | −47.9% | −42.3% | — |
| Return on invested capital (ROIC) | — | — | — | — | — | — | — | — | −20.0% |
| Return on assets (ROA) | −77.9% | −21.2% | −20.7% | −76.2% | −45.6% | −42.2% | −41.7% | −35.7% | −31.6% |
| Return on tangible assets | −70.2% | −31.5% | −26.4% | −79.6% | −45.6% | −34.8% | −46.1% | −19.7% | −31.6% |
| Free cash flow margin | — | −46.5% | −60.5% | −57.2% | — | — | — | — | — |
| Financial health | |||||||||
| Total debt | $719,000 | $384,000 | $824,000 | $10.2M | $10.6M | $9.9M | $9.7M | $200,000 | $16.1M |
| Cash & short-term investments | $30.3M | $22.6M | $40.9M | $71.0M | $80.7M | $82.2M | $53.1M | $65.9M | $7.1M |
| Net debt | −$29.6M | −$22.2M | −$40.0M | −$60.8M | −$70.2M | −$72.2M | −$43.5M | −$65.7M | $9.0M |
| Debt / equity | 0.03 | 0.02 | 0.04 | 0.32 | 0.16 | 0.14 | 0.23 | 0.00 | — |
| Debt / assets | 0.02 | 0.01 | 0.02 | 0.13 | 0.12 | 0.12 | 0.17 | 0.00 | 2.25 |
| Current ratio | 10.32 | 3.93 | 1.79 | 2.40 | 9.40 | 11.79 | 14.30 | 33.12 | 12.57 |
| Quick ratio | 10.32 | 3.93 | 1.79 | 2.40 | 9.40 | 11.79 | 14.30 | 33.12 | 12.57 |
| Interest coverage | — | — | -29.6 | -59.0 | -35.2 | -26.9 | -95.8 | -3.4 | -4.5 |
| Working capital | $27.3M | $18.6M | $21.8M | $44.7M | $74.8M | $78.2M | $51.7M | $65.1M | $6.6M |
| Invested capital | −$961,000 | −$3.1M | −$17.5M | −$28.9M | −$3.7M | −$2.4M | −$1.6M | −$778,000 | $6.8M |
| Tangible asset value | $28.6M | $19.1M | $22.6M | $31.9M | $66.5M | $69.9M | $41.8M | $64.9M | −$2.3M |
| Net current asset value | $27.0M | $18.4M | $21.4M | $30.3M | $64.9M | $69.9M | $41.8M | $64.9M | −$2.3M |
| Graham net-net per share | $0.29 | $0.48 | $0.51 | $0.82 | $2.15 | $3.27 | $2.27 | — | −$0.14 |
| Capital allocation | |||||||||
| Dividends paid | — | — | $9.1M | — | — | — | $9.9M | — | — |
| Share buybacks (net) | — | $0 | $260,000 | $0 | $0 | $0 | $156,000 | $0 | $0 |
| Capex / revenue | 36.9% | 0.2% | 0.1% | 1.8% | — | — | — | — | — |
| Capex / depreciation | 0.41 | 0.62 | 0.40 | 2.36 | 0.79 | 4.49 | 3.22 | 5.71 | 18.02 |
| Stock-based compensation / revenue | 1,786.2% | 9.1% | 11.1% | 30.7% | — | — | — | — | — |
| R&D / revenue | 9,879.2% | 91.1% | 102.6% | 238.3% | — | — | — | — | — |
| SG&A / revenue | 8,300.8% | 29.0% | 37.9% | 109.4% | — | — | — | — | — |
| Efficiency | |||||||||
| Days sales outstanding | 1,757.6 | 33.0 | 52.6 | 47.6 | — | — | — | — | — |
| Days payables outstanding | 5,397.9 | 9,835.0 | 12,578.0 | 8,045.5 | 10,116.1 | 18,813.7 | 23,740.9 | 40,757.2 | 729,225.1 |
| Cash conversion cycle (days) | -3,640.3 | -9,802.0 | -12,525.4 | -7,997.8 | — | — | — | — | — |
| Receivables turnover | 0.21 | 11.06 | 6.94 | 7.66 | — | — | — | — | — |
| Payables turnover | 0.07 | 0.04 | 0.03 | 0.05 | 0.04 | 0.02 | 0.02 | 0.01 | 0.00 |
| Asset turnover | 0.00 | 1.08 | 0.56 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | $626,000 | $3.7M | $5.2M | $2.1M | $0 | — | — | — | — |
| Average payables | $1.7M | $3.7M | $4.3M | $2.6M | $2.0M | $2.3M | $1.5M | $681,370 | $243,741 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% |
Computed from EQ's annual financial statements (latest annual report filed March 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
EQ valuation and financial ratios
Equillium earned a return on equity of −94.0% in fiscal 2025. It ended the year with $0.7 million of debt and $30.3 million in cash and short-term investments, a net cash position of $29.6 million. The share count rose 450.3% from 16.7M to 91.9M over 8 years.
See the EQ income statement, the EQ chart for price history, or the EQ stock overview for the latest quote and news.
EQ key metrics FAQ
What is Equillium's return on equity?
Equillium's return on equity (ROE) was −94.0% in fiscal 2025: net income of -$22.4 million on average shareholders' equity of $23.8 million.
How much debt does Equillium have?
Equillium had total debt of $0.7 million at the end of fiscal 2025, a debt-to-equity ratio of 0.03 and more cash than debt.
What is Equillium's free cash flow yield?
Equillium generated -$22.8 million of free cash flow in fiscal 2025, a free cash flow yield of −16.0% on its market value at year-end ($142.4 million).
What is Equillium's current ratio?
Equillium's current ratio was 10.32 at the end of fiscal 2025: current assets were 10.32 times current liabilities.